JESSICA L ARENAS

Allopathic & Osteopathic Physicians|Family Medicine GLENDORA, CA NPI 1982602397

General Payments — all program years on this page

$2,656.38

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 113
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,093.90 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,093.9039

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $440.9422
2022 $615.3829
2023 $506.1623
2024 $1,093.9039

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077925223 Janssen Pharmaceuticals, Inc $150.00 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080603522 Verity Pharmaceuticals Inc. $43.88 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749103 Novartis Pharmaceuticals Corporation $23.62 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749107 Novartis Pharmaceuticals Corporation $26.65 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749111 Novartis Pharmaceuticals Corporation $21.93 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103237481 ABBVIE INC. $19.68 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103237483 ABBVIE INC. $15.62 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103237485 ABBVIE INC. $25.19 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108564027 Novo Nordisk Inc $13.99 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108564579 Novo Nordisk Inc $19.13 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108565231 Novo Nordisk Inc $17.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108566915 Novo Nordisk Inc $20.95 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108570352 Novo Nordisk Inc $19.57 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108573096 Novo Nordisk Inc $22.61 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116249589 GlaxoSmithKline, LLC. $15.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116510583 GlaxoSmithKline, LLC. $31.90 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117496378 Amgen Inc. $14.71 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118260623 Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129461692 Esperion Therapeutics, Inc. $19.96 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129461694 Esperion Therapeutics, Inc. $15.12 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131808691 PFIZER INC. $19.84 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131995383 PFIZER INC. $24.55 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132003100 PFIZER INC. $19.94 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135645369 Lilly USA, LLC $23.99 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135705348 Lilly USA, LLC $34.56 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135705350 Lilly USA, LLC $27.00 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135705352 Lilly USA, LLC $34.81 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135707792 Lilly USA, LLC $24.00 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135720371 Lilly USA, LLC $24.55 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139478766 Astellas Pharma US Inc $25.00 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139554693 Astellas Pharma US Inc $22.22 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141979069 Merck Sharp & Dohme LLC $23.17 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150128022 SHIELD THERAPEUTICS INC $26.19 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153416060 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.46 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153479990 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.16 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153502758 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.84 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153526413 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.31 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153554133 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.54 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153747404 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.80 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.